Mark G Currie is President and CSO of Cyclerion Therapeutics, Inc.. Currently has a direct ownership of 251,648 shares of CYCN, which is worth approximately $830,438. The most recent transaction as insider was on Dec 28, 2020, when has been sold 20,107 shares (Common Stock) at a price of $3.01 per share, resulting in proceeds of $60,522. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 252K
0% 3M change
0% 12M change
Total Value Held $830,438

Mark G Currie Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 28 2020
SELL
Open market or private sale
$60,522 $3.01 p/Share
20,107 Reduced 7.4%
251,648 Common Stock

Also insider at

IRWD
IRONWOOD PHARMACEUTICALS INC Healthcare
MGC

Mark G Currie

President and CSO
Boston, MA

Track Institutional and Insider Activities on CYCN

Follow Cyclerion Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYCN shares.

Notify only if

Insider Trading

Get notified when an Cyclerion Therapeutics, Inc. insider buys or sells CYCN shares.

Notify only if

News

Receive news related to Cyclerion Therapeutics, Inc.

Track Activities on CYCN